<html><head></head><body><document>
<type>XML
<sequence>54
<filename>R7.htm
<description>IDEA: XBRL DOCUMENT
<text>


<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>


<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6792587072">
<tbody><tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note 1 - Basis of Presentation, Business Plan and Liquidity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&nbsp;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</a></td>
<td class="text"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> Basis of Presentation, Business Plan and Liquidity</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Description of Operations</div> – Novation Companies, Inc. and its subsidiaries (the “Company,” “Novation,” “we,” or “us”), through Healthcare Staffing, Inc. ("HCS"), our wholly-owned subsidiary acquired on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 27, 2017, </div>provides outsourced health care staffing and related services in the State of Georgia. Our common stock, par value <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> per share, is traded on the OTC Pink marketplace of the OTC Markets Group, Inc. under the symbol “NOVC”.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Liquidity and Going Concern</div> – During <div style="display: inline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div></div>, the Company incurred a net loss of $<div style="display: inline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10.2</div></div> million and generated negative operating cash flow of $<div style="display: inline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.2</div></div> million. As of <div style="display: inline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019</div></div>, the Company has an overall shareholders deficit of $<div style="display: inline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">72.1</div></div> million, an aggregate of $<div style="display: inline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.0</div></div> million in cash and cash equivalents and total liabilities of $<div style="display: inline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">91.5</div></div> million. Of the $<div style="display: inline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.0</div></div> million in cash, $<div style="display: inline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.7</div></div> million is held by the Company's subsidiary NovaStar Mortgage LLC ("NMLLC")<div style="display: inline; color:null;">.</div> This cash is available only to pay only general creditors and expenses of NMLLC.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">From <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2019 </div>through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2019, </div>the Company had a significant on-going obligation to pay interest under its senior note agreements at LIBOR plus <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.5%</div> per annum, payable quarterly in arrears until maturity on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 30, 2033, </div>leading to a significant annual cash outflow. In addition, HCS has experienced lower than anticipated cash flows due to increased costs and changes in customers. These items have led to substantial doubt about the Company's ability to continue as a going concern.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Management continues to work toward expanding HCS’s customer base by increasing revenue from existing customers, looking at methods to reduce overall operating costs, both at HCS and the corporate level, and targeting new customers that have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> previously been served by HCS. As disclosed in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div> to the consolidated financial statements, the Company was successful in amending the senior note agreements to lower the interest rate and receive future credit for cash interest payments made in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> in exchange for the issuance of common stock and warrants. Based on the terms of the amendment, the Company is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> required to make cash interest payments on the senior notes from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2019 </div>through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2022, </div>leading to significant cash savings for the Company.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">As discussed, the Amendment to the Note Purchase Agreement and waiver of interest payments through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2022, </div>has significantly improved our forecasted cash position over the next year.&nbsp; However, our historical operating results and poor cash flow suggest substantial doubt exists related to the Company's ability to continue as a going concern.&nbsp; In addition, based on the recent global developments regarding the coronavirus (COVID-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19</div>) situation, there is significant uncertainty regarding the potential impact to our business.&nbsp; Based on these uncertainties, there is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> guarantee the Company's cash position will cover current obligations. As a result, we have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> been able to alleviate the substantial doubt about the Company's ability to continue as a going concern for at least <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year after the date that these consolidated financial statements are issued.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Financial Statement Presentation.</div></div> The Company’s consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of income and expense during the period. The Company uses estimates and judgments in assessing the recoverability of goodwill and other intangible assets and accounting for income taxes, including the determination of the timing of the establishment or release of the valuation allowance related to the deferred tax asset balances and reserves for uncertain tax positions. While the consolidated financial statements and footnotes reflect the best estimates and judgments of management at the time, actual results could differ significantly from those estimates.</div></div><span></span>
</td>
</tr>
</tbody></table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tbody><tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tbody><tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</tbody></table></div>
</div></td></tr>
</tbody></table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tbody><tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tbody><tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</tbody></table></div>
</div></td></tr>
</tbody></table>
</div>


</text>
</description></filename></sequence></type></document>
</body></html>